46
Views
9
CrossRef citations to date
0
Altmetric
Original

Cytotoxic effect of R-etodolac (SDX-101) in combination with purine analogs or monoclonal antibodies on ex vivo B-cell chronic lymphocytic leukemia cells

, , , &
Pages 2625-2634 | Received 16 May 2006, Accepted 02 Aug 2006, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Tait D. Shanafelt, Kari G. Rabe, Neil E. Kay, Clive S. Zent, Timothy G. Call, Susan L. Slager, Deborah A. Bowen, Susan M. Schwager & Grzegorz S. Nowakowski. (2010) Statin and non-steroidal anti-inflammatory drug use in relation to clinical outcome among patients with Rai stage 0 chronic lymphocytic leukemia. Leukemia & Lymphoma 51:7, pages 1233-1240.
Read now
Pawel Robak, Piotr Smolewski & Tadeusz Robak. (2008) The role of non-steroidal anti-inflammatory drugs in the risk of development and treatment of hematologic malignancies. Leukemia & Lymphoma 49:8, pages 1452-1462.
Read now
Hiroshi Yasui, Teru Hideshima & Kenneth C. Anderson. (2006) Non-steroidal anti-inflammatory drug therapy for chronic lymphocytic leukemia. Leukemia & Lymphoma 47:12, pages 2445-2446.
Read now

Articles from other publishers (6)

Uri Rozovski, Michael J. Keating & Zeev Estrov. (2013) Targeting inflammatory pathways in chronic lymphocytic leukemia. Critical Reviews in Oncology/Hematology 88:3, pages 655-666.
Crossref
C. Pepper, J. G. Mahdi, A. G. S. Buggins, S. Hewamana, E. Walsby, E. Mahdi, A. Al-Haza’a, A. J. Mahdi, T. T. Lin, L. Pearce, L. Morgan, I. D. Bowen, P. Brennan & C. Fegan. (2011) Two novel aspirin analogues show selective cytotoxicity in primary chronic lymphocytic leukaemia cells that is associated with dual inhibition of Rel A and COX-2. Cell Proliferation 44:4, pages 380-390.
Crossref
Regina Razavi, Iris Gehrke, Rajesh Kumar Gandhirajan, Simon Jonas Poll-Wolbeck, Michael Hallek & Karl-Anton Kreuzer. (2011) Nitric Oxide–Donating Acetylsalicylic Acid Induces Apoptosis in Chronic Lymphocytic Leukemia Cells and Shows Strong Antitumor Efficacy In vivo . Clinical Cancer Research 17:2, pages 286-293.
Crossref
Iris Gehrke, Rajesh Kumar Gandhirajan & Karl-Anton Kreuzer. (2009) Targeting the WNT/β-catenin/TCF/LEF1 axis in solid and haematological cancers: Multiplicity of therapeutic options. European Journal of Cancer 45:16, pages 2759-2767.
Crossref
Suzanne Lentzsch, Gary Elliott & G. David Roodman. (2007) SDX‐308 and SDX‐101, Non‐Steroidal Anti‐Inflammatory Drugs, as Therapeutic Candidates for Treating Hematologic Malignancies Including Myeloma. Archiv der Pharmazie 340:10, pages 511-516.
Crossref
Tadeusz Robak, Piotr Smolewski, Barbara Cebula, Olga Grzybowska-Izydorczyk & Jerzy Z. Błoński. (2007) Rituximab plus cladribine with or without cyclophosphamide in patients with relapsed or refractory chronic lymphocytic leukemia. European Journal of Haematology 79:2, pages 107-113.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.